Erythrocyte pyruvate kinase deficiency. A kinetic study of the membrane-localised and cytoplasmatic enzyme from six patients
- PMID:6851994
Erythrocyte pyruvate kinase deficiency. A kinetic study of the membrane-localised and cytoplasmatic enzyme from six patients
Abstract
Investigations on the activity and the kinetic behavior of red cell pyruvate kinase in the erythrocyte membrane and hemolysate of 6 patients with pyruvate kinase (PK) deficiency are presented and compared with those of normal individuals. Hemolysate: The PK in the hemolysate of normal individuals showed the well-known allosteric properties, reflected by sigmoidal reaction kinetics (Hill-coefficient greater than 1). In contrast to these findings the enzymes of 4 of the patients which had not been splenectomised and which were all in satisfactory condition showed between 15 and 35% of the PK activity of normal individuals in the hemolysates, whereas in the case of the 2 splenectomised patients only 5 and 15% of this activity could be measured. All of the patients' enzymes showed non allosteric (hyperbolic) reaction kinetics (Hill-coefficient approximately 1.0). Red cell membranes: Our studies confirmed earlier reports that not only the hemolysate of the patients, but also their red cell membranes ('ghosts') exhibit PK activity. In normal individuals the activity of the membrane-localised PK is about 5% of the cytoplasmatic one. In case of the membrane-localised enzyme of all patients--irrespective if they were splenectomised or not--the activity is decreased to 30-50%, compared to the activity of ghosts of the control persons. Reaction kinetic studies on the PK isolated from red cell membranes from normal individuals as well as from all 6 patients exhibited hyperbolic Michaelis-Menten kinetics with Hill coefficients around 1.0.
Similar articles
- Erythrocyte pyruvate kinase deficiency. The influence of physiologically important metabolites on the function of normal and defective enzymes.Lakomek M, Winkler H, Pekrun A, Krüger N, Sander M, Huppke P, Schröter W.Lakomek M, et al.Enzyme Protein. 1994-1995;48(3):149-63.Enzyme Protein. 1994.PMID:8589802
- [Significance of kinetic abnormalities of erythrocyte pyruvate kinase in congenital deficiencies].Boivin P, Galand C.Boivin P, et al.Pathol Biol (Paris). 1977 Mar;25(3):161-7.Pathol Biol (Paris). 1977.PMID:323784French.
- An inherited molecular lesion of erythrocyte pyruvate kinase. Identification of a kinetically aberrant isozyme associated with premature hemolysis.Paglia DE, Valentine WN, Baughan MA, Miller DR, Reed CF, McIntyre OR.Paglia DE, et al.J Clin Invest. 1968 Aug;47(8):1929-46. doi: 10.1172/JCI105883.J Clin Invest. 1968.PMID:5666119Free PMC article.
- [Erythrocyte pyruvate kinase--an enzyme that may have an influence on oxygen transport to tissues].Dabrowska A.Dabrowska A.Postepy Hig Med Dosw. 1997;51(3):305-18.Postepy Hig Med Dosw. 1997.PMID:9333782Review.Polish.
- Red cell pyruvate kinase deficiency: molecular and clinical aspects.Zanella A, Fermo E, Bianchi P, Valentini G.Zanella A, et al.Br J Haematol. 2005 Jul;130(1):11-25. doi: 10.1111/j.1365-2141.2005.05527.x.Br J Haematol. 2005.PMID:15982340Review.